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Abstract
Expression quantitative trait loci (eQTL) studies are used to understand the regulatory func-
tion of non-coding genome-wide association study (GWAS) risk loci, but colocalization
alone does not demonstrate a causal relationship of gene expression affecting a trait. Evi-
dence for mediation, that perturbation of gene expression in a given tissue or developmental
context will induce a change in the downstream GWAS trait, can be provided by two-sample
Mendelian Randomization (MR). Here, we introduce a new statistical method, MRLocus, for
Bayesian estimation of the gene-to-trait effect from eQTL and GWAS summary data for loci
with evidence of allelic heterogeneity, that is, containing multiple causal variants. MRLocus
makes use of a colocalization step applied to each nearly-LD-independent eQTL, followed
by an MR analysis step across eQTLs. Additionally, our method involves estimation of the
extent of allelic heterogeneity through a dispersion parameter, indicating variable mediation
effects from each individual eQTL on the downstream trait. Our method is evaluated against
other state-of-the-art methods for estimation of the gene-to-trait mediation effect, using an
existing simulation framework. In simulation, MRLocus often has the highest accuracy
among competing methods, and in each case provides more accurate estimation of uncer-
tainty as assessed through interval coverage. MRLocus is then applied to five candidate
causal genes for mediation of particular GWAS traits, where gene-to-trait effects are concor-
dant with those previously reported. We find that MRLocus’s estimation of the causal effect
across eQTLs within a locus provides useful information for determining how perturbation of
gene expression or individual regulatory elements will affect downstream traits. The MRLo-
cus method is implemented as an R package available at https://mikelove.github.io/
mrlocus.
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Author summary
Genome-wide association studies (GWAS) have identified many loci associated with com-
plex traits and diseases. Expression quantitative trait loci (eQTL) may help to explain
mechanisms of GWAS associations, if the gene has a role as a mediator of the trait or dis-
ease. Loci that exhibit allelic heterogeneity, that is, loci containing multiple causal variants,
offer the opportunity to investigate whether effects are concordant and proportional
across eQTL and GWAS; if the gene is a partial mediator of the trait, the sign and size of
the effects across distinct eQTL variants should be reflected in GWAS associations. Such a
Mendelian Randomization (MR) analysis of individual loci is complicated by moderate
sample sizes in eQTL studies and linkage disequilibrium (LD), resulting in complex pat-
terns of estimated effect sizes for eQTL and GWAS. We develop a statistical model,
MRLocus, with two steps: selection of eQTL SNPs to act as instruments in the MR analysis
of a genetic locus, and estimation of the gene-to-trait mediation effect taking instrument
uncertainty into account. In simulation, the method has higher accuracy and better uncer-
tainty measures compared to other competing methods, and we compare its estimates on
candidate causal gene-trait pairs from literature.
Introduction
Genome-wide association studies (GWAS) have identified many loci associated with complex
traits and diseases. A major goal now is to understand the mechanism by which non-coding
genetic variation influences trait levels through changes in gene expression. This involves iden-
tifying the causal variants at a locus, determining if the same variants are associated with both
gene expression and trait, and disambiguating mediation from pleiotropy [1]. Proposing medi-
ating genes from existing expression quantitative trait loci (eQTL) and GWAS resources will
lead to experiments that test whether modulating gene expression influences traits, and there-
fore inform further research and development of treatments.
Current efforts to identify the genes underlying GWAS risk often make use of either coloca-
lization of GWAS signal with eQTLs, or expression imputation. In colocalization, statistical
models are used to probabilistically assess if the same genetic variants within a locus are likely
to be causally contributing to both eQTL and GWAS signals, taking into account the structure
of linkage disequilibrium (LD) for a given population [2–8]. Expression imputation methods,
as in transcriptome-wide association studies (TWAS), add additional information by includ-
ing subthreshold signal for both GWAS and eQTL to identify which genes’ expression may
have a non-zero local genetic correlation with a given GWAS trait [9–11]. Further refinements
of TWAS statistical models have allowed for probabilistic fine-mapping within loci harboring
multiple candidate genes by accounting for LD structure, as in FOCUS [11].
Though colocalization and expression imputation suggest genes involved in a trait, neither
method is designed to disambiguate between pleiotropy and mediation. The latest generation
of methods for determining those genes involved in mediating GWAS signal have combined
the approaches of colocalization and expression imputation with statistical techniques from
the field of Mendelian randomization (MR) [12–14], as evaluated and reviewed recently
[15,16]. Intuitively, these methods work by determining if those genetic variants which influ-
ence gene expression also influence a downstream trait in proportionate degrees. Evidence for
mediation is provided by randomized genetic variation used to perturb gene expression and
observing the expression effects propagated to traits. With access to genotype, expression, and
trait data, classical mediation techniques can be employed, as in the methods CIT [17] and
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SMUT [18], while MR-link [19] makes use of individual-level data from a GWAS study and
summary statistics for eQTL to perform MR analysis.
Other methods testing gene-to-trait mediation require only summary statistics from eQTL
and GWAS studies, as it is rarely possible to have access to the per-participant genotypes,
expression values, and GWAS trait values [20]. Methods such as CaMMEL [21], TWMR [22],
LDA-MR-Egger [23], PMR-Summary-Egger [24], PTWAS [25], MESC [1], MR-Robin [26]
allow for estimation of gene-to-trait effects from eQTL and GWAS summary statistics, integrat-
ing across multiple SNPs within a locus. The ability to accurately estimate the gene-to-trait
mediation effect within a locus relies on having multiple independent “instruments”, SNPs
which are found to be associated with the potential mediator (gene expression), and which plau-
sibly only affect the downstream trait through the mediator. Across studies, between 29–50% of
genes provide evidence for allelic heterogeneity, that is, having more than one independent cis-
eQTL per gene, with estimates varying by tissue and study sample size [27–29]. Some genes pro-
vide evidence for up to 13 independent cis-eQTL signals, detected by conditional analysis in
peripheral blood [28]. A recent study integrating neonatal gene expression with GWAS of auto-
immune and allergic disease performed MR analysis across 52 genes that had three or more cis-
eQTLs [30]. Therefore, while not all genes display allelic heterogeneity at current eQTL study
sample sizes, it is common enough to allow for mediation modeling of many candidate genes.
Existing methods for assessing whether expression of a particular gene in some context
may mediate GWAS signal have primarily focused on their ability to perform genome-wide
mediation scans across multiple tissues or cell types. This is a critical task in determining the
genetic architecture and the most relevant molecular contexts for a trait (e.g. tissues, cell types,
or developmental stage) which are often not known a priori. However, when considering func-
tional follow-up experiments at an individual locus, investigators may weigh accurate quantifi-
cation of the uncertainty regarding a potential gene-to-trait effect, as well as the heterogeneity
of gene-to-trait effects across signal clusters within a locus.
Here, we propose MRLocus, a Bayesian model for estimating the gene-to-trait effect from
multiple independent signal clusters for one gene, as well as for estimating the heterogeneity of
the effects across clusters. We have designed our method for prioritization of genes in functional
experiments, where the genes under study have already been identified as candidates for media-
tion, having emerged from one of the global mediation scanning methods described above, or
from colocalization or TWAS. MRLocus performs estimation of the gene-to-trait effect itself, as
our focus is on experimental follow-up, as opposed to estimation of the percent of mediated
heritability. In comparisons with other recently developed methods for identifying mediating
genes from eQTL and GWAS summary data and LD matrices, TWMR and PTWAS, MRLocus
was often more accurate in estimation of the gene-to-trait effect across simulated eQTL and
GWAS experiments, and had higher and closer to nominal coverage of the true effect when
considering its credible intervals. Using existing eQTL and GWAS data, we also estimate media-
tion effects at previously reported and experimentally validated loci. The MRLocus method is
implemented as an open source R package with full function documentation and a software
vignette demonstrating its use, publicly available at https://mikelove.github.io/mrlocus.
Materials and methods
MRLocus method
MRLocus consists of two steps, (1) colocalization and (2) MR slope fitting, each of which use
Bayesian hierarchical models specified in the Stan probabilistic programming language, and
with posterior inference using the Stan and RStan software packages [31]. As in PTWAS [25],
MRLocus estimates the gene-to-trait effect or slope by identifying "nearly-LD-independent"
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signal clusters and then assessing the strength of evidence of mediation and the heterogeneity
of the allelic effects. We refer to "nearly-LD-independent" clusters meaning non-overlapping
sets of SNPs with low LD: MRLocus first uses PLINK’s clumping algorithm [32] with r2 < 0.1
to identify signal clusters, sets of SNPs correlated with gene expression based on eQTL p-value
(as discussed below), whereas PTWAS uses DAP [33] for identifying signal clusters. MRLocus
additionally performs trimming of signal clusters to ensure r2 < 0.05 for cluster representative
SNPs, first using across-cluster r2 based on index SNP, then later using the candidate causal
SNP from the colocalization step. Here, "trimming clusters" refers to removing clusters, priori-
tizing those clusters with lower index SNP eQTL p-value. Alternatively, conditional analysis
could be used as discussed in a recent coloc methods paper [34]. As with other gene mediation
methods mentioned above, we focus here on common SNPs (using a minor allele frequency
(MAF) filter on real and simulated data of 0.01). To the extent that a SNP or genetic variant
gives rise to both the eQTL and GWAS signal and is in the set analyzed by MRLocus, then the
model has a chance to find the "causal” SNP, although in general MRLocus may identify a SNP
which is in high LD with the causal SNP.
In contrast to other methods for estimating gene-to-trait effects, MRLocus additionally per-
forms a colocalization step prior to slope fitting, using eQTL and GWAS summary statistics
(estimated coefficients and standard errors (SE)), based on LD matrices (either distinct matri-
ces when eQTL/GWAS are performed in different populations, or a single shared matrix can
be used when eQTL/GWAS are performed in the same population). The colocalization step
attempts to identify a single candidate causal SNP per nearly-LD-independent signal cluster.
Here “candidate causal SNP” refers to the hypothesis that the SNP gives rise to both the
observed eQTL and GWAS signal, given the LD matrices. The colocalization step produces
posterior estimates that assess the degree to which the summary statistics and LD matrices sup-
port the causal hypothesis per signal cluster (see S1 Methods for details on the statistical
model). If the SNP is a strong candidate for causing both the eQTL and GWAS signal in a sig-
nal cluster, then the posterior estimates for the eQTL and GWAS effect sizes will be large (in
absolute value) for the SNP, and near 0 for the other SNPs. If the SNP is a strong candidate for
only the eQTL signal, but not for the GWAS signal, then the posterior estimate for the chosen
SNP for the GWAS signal will be near 0. Finally, we note that prior to the colocalization step,
MRLocus performs collapsing of highly correlated SNPs (threshold of 0.95 correlation), such
that the final "per-SNP" results actually correspond to results for representatives from sets of
highly correlated SNPs. MRLocus also performs allele flipping such that all SNPs are coded to
be in positive LD correlation to the index SNP that has a positive estimated coefficient for
eQTL (S1 Methods). This ensures that the statistical modeling and visualizations are always
referring to the effect of an expression-increasing allele.
MRLocus’s colocalization step is motivated by the eCAVIAR model [5] as it formulates a gen-
erative model for the summary statistics based on true underlying signals, but is distinct from the
eCAVIAR model in two respects. First, eCAVIAR models the z-scores from eQTL and GWAS,
while MRLocus directly models the estimated coefficients, as our focus is on estimation of the
gene-to-trait effect, which can be conceived as in other MR applications as a regression of coeffi-
cients from GWAS on eQTL. eCAVIAR does not output posterior effect sizes for the two studies,
which is the originally intended input to MRLocus slope estimation. Second, eCAVIAR uses a
multivariate normal distribution to model the vector of observed z-scores in a locus, while MRLo-
cus uses a univariate distribution to model the estimated coefficients of the SNPs in each nearly-
LD-independent signal cluster. The univariate distribution was chosen for its increased perfor-
mance in accuracy and in efficiency in model fitting, as well as for flexibility in specification of
prior distributions. As the methods have distinct but related functionality, we also assessed the use
of eCAVIAR in lieu of MRLocus’s colocalization step, for choice of candidate causal SNPs to
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provide to the subsequent slope fitting step (referred to here as "eCAVIAR-MRLocus"). As with
MRLocus colocalization, clusters are trimmed such that across-cluster r2< 0.05 based on eCA-
VIAR chosen SNPs, but collapsing of highly correlated SNPs is not performed, as it is not required
for eCAVIAR input. The SNP with largest colocalization posterior probability (CLPP) is chosen
among those SNPs with p-value below the clumping threshold.
In its implementation of colocalization, MRLocus uses a horseshoe prior [35] on the true
coefficients for eQTL and GWAS signal per signal cluster, which helps to induce sparsity in
the posterior estimates of the coefficients prior to mediation analysis (S1 Methods). The pro-
posed use of the horseshoe prior during colocalization to identify putative causal SNPs from
eQTL and GWAS coefficients within a signal cluster is distinct from other Bayesian MR meth-
ods’ use of the horseshoe prior on pleiotropic effects or on the mediation slope [36–38].
MRLocus’s slope fitting step involves estimation of the gene-to-trait effect across signal
clusters (Fig 1). For slope estimation, the best candidate SNP per nearly-LD-independent sig-
nal cluster is chosen, based on which SNP has the largest posterior mean of the eQTL effect
size from the colocalization step. A hierarchical model is used to perform inference on param-
eters of interest, in this case the slope (α) of true GWAS coefficients on true eQTL coefficients.
In contrast to a typical inverse-variance weighted MR slope estimation, MRLocus additionally
includes uncertainty on the effect size of the instruments, which we find leads to better cover-
age properties of credible intervals in simulated datasets. For study of putative mediator A (e.g.
eQTL) and downstream trait B (e.g. GWAS), the following hierarchical model is fit using esti-



















Fig 1. MRLocus estimates the gene-to-trait effect (solid blue line) as the slope from paired eQTL and GWAS effect
sizes from independent signal clusters (black points with standard error bars), here on simulated coefficients. The
dispersion of allelic effects around the main gene-to-trait effect (light blue band) is also estimated. An 80% credible
interval on the slope is indicated with dashed blue lines sloping above and below the solid blue line. Panels represent
loci demonstrating (A) mediation with low dispersion, (B) mediation with high dispersion, and (C) colocalization of
eQTL and GWAS signals but no evidence of mediation (slope credible interval overlaps 0). Investigators may wish to
prioritize loci for experimental follow-up in which a typical “dosage” pattern is observed, such that alleles contributing
small amounts to expression of a gene contribute small amounts to GWAS trait, and similarly for large effect alleles.
https://doi.org/10.1371/journal.pgen.1009455.g001
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Details regarding setting of priors for the hyperparameters SDβ (the prior for the instru-
ment effect sizes), α (the gene-to-trait slope), and σ (the dispersion of signal cluster effect sizes
around the fitted line) are provided in the S1 Methods. If the signal cluster does not provide
evidence of colocalization, the estimate of the GWAS coefficient from the previous step will be
near 0, and this will bring the estimated slope toward 0 as well. If the eQTL and GWAS esti-
mated coefficients are based on standardized expression and traits, then α2 can be interpreted
as the mediated trait variance explained in the samples. Quantile-based credible intervals on
the slope coefficient provide information regarding the uncertainty of the gene mediating the
trait measured in the GWAS. Finally, whereas PTWAS makes use of an I2 statistic [39] for
quantifying the heterogeneity of the allelic effects at the locus, MRLocus estimates the disper-
sion (σ) of the different allelic effects around the predicted values given by the slope. Therefore,
MRLocus may have high certainty on the slope (narrow credible interval for α not overlapping
0), while nevertheless estimating that the dispersion of allelic effects around the slope is large
(σ). The tradeoff between uncertainty on the estimate of α and the dispersion σ of allelic effects
around fitted line naturally depends upon the number of independent signal clusters at the
locus. For loci with no allelic heterogeneity, we do not recommend running MRLocus (the
software will produce a warning), and do not evaluate MRLocus on such loci here.
Choice of methods for comparison
We chose to focus on TWMR [22] and PTWAS [25] in our comparisons, as these two methods
had a focus on estimation of the gene-to-trait effect, were able to run on eQTL data for a single
gene and a single tissue, and required only summary statistics and LD matrices. PTWAS adds
to the analysis of gene-to-trait effects an upstream fine-mapping of cis-eQTL using DAP [33],
and estimation of gene-to-trait effect heterogeneity in the case of multiple independent eQTL
signal clusters, employing an I2 statistic that ranges between 0 and 1. The I2 statistic represents,
in the gene-to-trait meditation case, the percent of variance in estimated effect sizes across sig-
nal clusters that arises from true effect heterogeneity.
We additionally compared MRLocus to LDA-MR-Egger [23] and PMR-Summary-Egger
[24] on the first simulation setting. Other methods that likewise determine if one or more
genes may mediate traits include SMR [40,41], CaMMEL [21], MESC [1], MR-Robin [26].
SMR uses the top cis-eQTL per gene to compute gene-to-trait effects, and was extended to
SMR-multi [41] to perform null hypothesis testing across multiple SNPs per gene, but it does
not offer an integrated estimate of the causal effect. We were not able to run CaMMEL using
only LD matrices from the eQTL and/or GWAS cohort, as the fit.med.zqtl function takes
genotype design matrices as input. We were not able to run MESC with less than 5 genes,
while our focus with MRLocus is on single gene mediating effect estimation. MR-Robin also
provides robust estimates of gene-to-trait effects but with a focus on multiple-tissue eQTL
summary statistics as input.
Simulation
For simulation, we used the pre-existing TWAS simulation framework, twas_sim [42], which
simulates eQTL and GWAS datasets using real genotype data (1KG EUR Phase3) and outputs
summary statistics. This software has a number of options for simulation parameters including
cis heritability of gene expression (referred to here as "h2g"), expression mediated trait herita-
bility (referred to here as "h2med"), and the number of SNPs in a locus which are cis eQTL. A
single gene’s expression was simulated per experiment, and both gene and trait were scaled to
unit variance for slope estimation. The key twas_sim simulation equations follow. For a study
with N individuals, concerning a locus with n SNPs, let the distribution of eQTL effect sizes
PLOS GENETICS MRLocus: identifying causal genes mediating a trait through Bayesian estimation of allelic heterogeneity
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j � Nð0; h
2g=ncausalÞ:
The generation of a vector of gene expression ygene for N individuals is given by:







εindiv � Nð0; s
2
errÞ
ygene ¼ Z b
eQTL
þ ε;
where V̂ is a function for the unbiased sample variance, Z is an N x n matrix of zero-centered,
unit variance genotypes, βeQTL is a column vector of sampled true eQTL effect sizes which is
equal to 0 everywhere except for the causal SNPs βj
eQTL, and ε is a column vector of errors for
individuals 1 to N. A column vector of errors, ε, are drawn from a zero-centered normal with
variance s2err. Finally, ygene is standardized to unit variance before eQTL coefficients are esti-
mated. The simulated GWAS trait ytrait for a separate set of individuals is generated as above
but using h2med in place of h2g, and where the same set of causal (non-zero effect size) SNPs
are used for βeQTL and βGWAS:







εindiv;trait � Nð0; s
2
err;traitÞ
ytrait ¼ Z b
GWAS
þ εtrait:
This provides gene expression and trait with population-level heritability given by h2g and
h2med (the simulated individuals are drawn from an infinite population and so the heritability
in the finite sample may differ). Finally, the true gene-to-trait slope α is calculated as the ratio
of βj
GWAS / βj
eQTL for causal SNPs j, after scaling coefficients by the sample standard deviation
for ygene and ytrait. Therefore, in the simulations we have the approximate relationship (see also
S1 Method):
h2med ffi h2g a2
Simulations of paired eQTL and GWAS datasets were performed where the gene was a par-
tial mediator of the trait, as well as null simulations where the gene expression was unrelated
to the downstream trait and the locus contains multiple trait-only association signals (the
same causal SNP percent as for eQTL). An additional simulation was performed in which the
gene is a partial mediator of the trait, and three large effect trait-only association signals are
added to the causal SNP set for simulating the GWAS study. This simulation was performed to
assess the methods’ accuracy in the presence of horizontal pleiotropy, and code for this simula-
tion can be found in the ‘hp’ branch of the forked repository: https://github.com/mikelove/
twas_sim/tree/hp. Null simulations were obtained by running twas_sim with two different
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seeds on the same locus to produce a set of GWAS trait signals not mediated by gene expres-
sion: a distinct set of causal SNPs with unrelated effect sizes.
TWMR, PTWAS, MRLocus, eCAVIAR-MRLocus, LDA-MR-Egger, and PMR-Summary-
Egger were all run on the same summary data from eQTL and GWAS simulations. The Snake-
make software [43] was used for automation of simulation scripts including specification of
random seed for each of the simulations, in order to assist with computational reproducibility
of simulations. Simulation and analysis code is provided at https://github.com/mikelove/
mrlocusPaper. The sample sizes for eQTL and GWAS were kept at their default values of
NeQTL = 500 and NGWAS = 100,000, respectively, and an additional simulation was performed
with NeQTL = 1,000. The percent of SNPs in a locus which are eQTLs was set to 1%. The
parameter h2g was varied from its default value (0.1) to a higher value (0.2) and a lower value
(0.05), and the expression mediated trait heritability (h2med) was varied from its default value
(0.01) to two lower values (0.005, 0.001, as well as to 0 indicating a null simulation where gene
expression does not explain variation in a GWAS trait). Each combination of 3 (for h2g) x 4
(for h2med) resulted in 12 simulations (with labels A-I, Null-0.1, Null-0.2, and Null-0.05) plus
two additional simulations for partial mediation with horizontal pleiotropy (HP) and higher
NeQTL (High-N), totaling 14 simulation types (Fig A in S1 Text). 20 iterations of each simula-
tion were drawn, and if this did not produce at least 18 iterations with allelic heterogeneity
(two or more index eSNPs with p-value < 0.001 and pairwise r2 < 0.05), then 20 more itera-
tions were drawn. 40 iterations of the main (A) simulation, the horizontal pleiotropy (HP)
simulation, and the higher NeQTL (High-N) simulation were drawn. If a method did not pro-
duce output for an iteration due to insufficient input data, e.g. no signal clusters with
PIP > 0.5 for PTWAS, or < 2 nearly-LD-independent signal clusters for MRLocus, then a
slope estimate of 0 is plotted in the simulation accuracy figures. The error rate and coverage
for a method was calculated only over those iterations that the method produced an estimate.
All methods except for PMR-Summary-Egger ran without error on all iterations.
LD-based clumping implemented in PLINK (v1.90b) [32] was performed on eQTL simula-
tion un-adjusted p-values with the following settings:—clump-p1 0.001—clump-p2 1—clump-
r2 0.1—clump-kb 500. All PLINK clumps were provided to TWMR (commit 62994ec) [22]
and MRLocus (v0.0.22) for gene-to-trait effect estimation. PTWAS (v1.0) [25] was provided
with output from DAP (DAP-G, commit ac38301) [33] with settings: -d_n NeQTL -d_syy
NeQTL (as twas_sim scales expression to unit variance). PTWAS code was modified (at line 97
for commit b5714f3) to allow for input of estimated coefficients and their SE, such that it pro-
vided slope estimates on the original scale of coefficients, not z-scores. LDA-MR-Egger and
PMR-Summary-Egger (v1.0) were supplied with the eQTL and GWAS summary statistics of
the locus and the LD matrix, without clumping. For 1–2 simulation iterations, LDA-MR-Egger
or PMR-Summary-Egger would output a very large estimate of α (> 2 in absolute value), and
these large estimates were removed to give more representative error rates for these two meth-
ods. PMR-Summary-Egger does not provide an SE of the causal effect in its output so was
excluded from coverage evaluation. eCAVIAR (v2.2) was run per nearly-LD-independent sig-
nal cluster with -c 1 (maximum of one causal SNP), without collapsing of highly correlated
SNPs, as an alternative to MRLocus colocalization step. For eCAVIAR-MRLocus, the SNP
with highest CLPP among those with p-value less than the PLINK clumping threshold was
provided from each signal cluster to the slope fitting step. For all simulations, if there were no
SNPs in the simulated locus with eQTL un-adjusted p-value < 0.001 then a new seed was
drawn. Furthermore, all methods were only evaluated on loci with evidence of allelic heteroge-
neity, as demonstrated by more than one nearly-LD-independent (r2 < 0.05) signal cluster
with index eQTL p-value< 0.001. For simulation comparisons, MR with inverse variance
weighted (IVW) regression with fixed effects [44] was computed using the true causal eQTLs
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("causal") or across all SNPs ("all") using the mr_ivw_fe function in the TwoSampleMR R pack-
age (v0.5.5) [45] with eQTL as the exposure study and GWAS as the outcome study. The
"causal" IVW MR analysis served as an "oracle" estimator in the simulations, as it was provided
with information not available in a typical analysis and not provided to other methods. The
number of true eQTL SNPs, PLINK clumps, DAP signal clusters, and clusters passing 1st and
2nd round of r2-based trimming are shown in Fig B in S1 Text. The distribution of the number
of SNPs per clump before and after collapsing highly correlated SNPs (part of MRLocus pre-
processing, described in S1 Methods) is shown in Fig C in S1 Text.
In order to assess whether trimming signal clusters to obtain pairwise r2 < 0.05 would be
sufficient to protect against false positives for MRLocus slope fitting resulting from correlated
instruments, a simulation was performed across a range of r2. Estimated eQTL and GWAS
coefficients for between J = 4, 6, or 8 signal clusters were generated from a multivariate normal
distribution, such that the population correlation between adjacent signal clusters took on a
specific r2 value, and all other pairs had correlation of 0. The mean vector for the eQTL (A)
study was centered on [10,. . .,10], while the mean vector for the GWAS (B) study was centered
on the origin, such that the true gene-to-trait slope is α = 0. These coefficients and their stan-
dard errors were provided to the slope estimation step of MRLocus, and 80% credible intervals
were calculated for 400 iterations per combination of J and r2. The code for this simulation is
provided in the corr_instr_sim directory of the mrlocusPaper GitHub repository.
By producing signal clusters with PLINK clump using—clump-p1 0.001, this ensures that
the index eSNP for each signal cluster has an absolute Z-score of> ~3.3, or equivalently an F-
statistic > ~10.8. In order to assess whether even stronger criteria on the strength of the signal
clusters provided to MRLocus would improve accuracy of the gene-to-trait effect, we re-ran
PLINK clump on the main (A) simulation and the high NeQTL simulation using—clump-p1
0.0001 (F-statistic > ~15.1), and re-ran TWMR and MRLocus. Such estimates for TWMR and
MRLocus are referred to using "_p1e-4" in the Results. As PTWAS did not always produce esti-
mates on simulated loci due to insufficient signal clusters with posterior inclusion probability
(PIP) > 0.5, we additionally tested PTWAS on the A and high NeQTL simulations using signal
clusters with PIP > 0.1, referred to as "_t0.1" in the Results.
Two additional assessments of the simulation datasets were performed, to better understand
underlying factors that may explain differences in method performance. For MRLocus and
eCAVIAR colocalization steps, the accuracy in recovering the causal eSNPs was assessed across
the different simulation settings. Specifically, for signal clusters containing a true causal eSNP,
the SNP chosen as the candidate instrument from each signal cluster for slope fitting was evalu-
ated as to whether it was equal to or in high correlation (r> 0.95) with the causal eSNP. The
accuracy was then computed by averaging over all signal clusters from all iterations of the simu-
lation. Additionally, the coverage of true values by confidence or credible intervals was assessed
using information about the true simulated value. As insufficient coverage could occur due to
estimation bias or badly calibrated standard errors, for three simulations with h2g of 10% (A, D,
G), we calculated the bias for TWMR, PTWAS, MRLocus, and eCAVIAR-MRLocus, using the
sample mean of the estimates and the population-level true alpha value of (h2med / h2g)-1/2. We
then re-computed the interval coverage after subtracting the bias. While these "oracle" bias-
adjusted coverage values could not be obtained in real settings, they help to answer whether cor-
rection of estimation bias alone would resolve problems with insufficient coverage.
Real data analysis
To evaluate the performance of methods on real data, we applied TWMR, PTWAS, and
MRLocus to five candidate causal genes for mediation of particular GWAS traits, chosen based
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on literature review of previous connections between gene expression and downstream pheno-
type: SORT1 (liver)—low-density lipoproteins (LDL), MRAS (tibial artery)—coronary artery
disease (CAD), PHACTR1 (tibial artery)—CAD, CETP (liver)—high-density lipoproteins
(HDL), and LIPC (liver, as well as in blood)—HDL. eQTL and GWAS summary data were
obtained as summarized in Table A in S1 Text. Briefly, eQTL data on tibial artery, blood, and
liver was obtained from the Genotype-Tissue Expression (GTEx) project v8 [46], eQTLGen
Consortium 2019-12-23 release [47], and directly from the authors of a liver meta-analysis
study [48], respectively. GTEx v8 estimated eQTL coefficients were on the scale of unit vari-
ance expression values (following per-gene inverse normal transformation), eQTLGen esti-
mated coefficients and standard errors were derived from z-scores and MAF as indicated by
the README for SMR input, while the liver meta-analysis estimated coefficients were on the
scale of log2 normalized expression, according to references. GWAS summary statistics on
CAD were obtained from CARDioGRAMplusC4D (Coronary ARtery DIsease Genome wide
Replication and Meta-analysis (CARDIoGRAM) plus The Coronary Artery Disease (C4D)
Genetics) consortium [49], where coefficients represent log odds ratios (OR), and the UK Bio-
bank (https://www.ukbiobank.ac.uk) obtained from http://www.nealelab.is/uk-biobank/,
where coefficients are estimated with respect to unit variance, continuous scale HDL or LDL.
Prior to defining independent signal clusters, we filtered out SNPs with MAF < 0.01 from
GWAS data, and p-values were corrected with lambda GC [50]. We used raw p-values for
eQTL data and genomic control corrected p-values for GWAS data. As our task for down-
stream inference is estimation of the slope of GWAS coefficients over eQTL coefficients across
signal clusters, it is not necessary that the eQTL signal clusters attain genome-wide significance
before being provided to MRLocus. We first identified nearly-LD-independent signal clusters
for eQTL by LD-based clumping implemented in PLINK (1.90b) [32] with the following set-
tings:—clump-p1 0.001—clump-p2 1—clump-kb 500—clump-r2 0.1 (as in the simulation set-
ting). LD was estimated in the European population from the 1000 Genome Project phase 3
(1KG EUR). Next we directly obtained test statistics of matched SNPs in each eQTL cluster
from GWAS summary data.
Generating MRLocus input files
For each independent pair, we generated MRLocus input files (effect size tables) with esti-
mated coefficients, SE, and reference and effect alleles from both eQTL and GWAS. Pairwise
LD (Pearson’s r) between SNPs were generated by the PLINK—r function for all SNPs
included in the corresponding effect size table using 1KG EUR. We also included major/
minor allele information from the reference panel (PLINK bim files) in the effect size table for
proper allele flipping for statistical modeling and visualization (S1 Methods).
Real data analysis with other methods
TWMR and PTWAS were used to compare estimates on real data loci. Both software packages
require definition of eQTL signal clusters and we used DAP (DAP-G, commit ac38301) to esti-
mate independent eQTL clusters for PTWAS (v1.0) as described in the original paper, while
for TWMR (commit 62994ec) we ran PLINK clumping with the same parameters we used for
MRLocus (v0.0.22) (c.f. the original TWMR paper performed approximate conditional analy-
ses). DAP was applied to estimated coefficients and SE from eQTL summary statistics with
default options except we set maximum models (-msize) to 20. For the CETP locus, there were
not any signal clusters for PTWAS with sufficient posterior inclusion of probability (all signal
cluster PIP < 0.5), so the threshold was lowered to 0.1 in order to visualize an estimate and
interval.
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Results
Simulation
In order to evaluate the accuracy in estimating the mediated gene effect, we used a GWAS and
eQTL simulation. The twas_sim simulation framework used for evaluating methods has
default values for cis eQTL gene expression heritability of 10% (h2g) and expression mediated
trait heritability of 1% (h2med). As the eQTL-based gene expression heritability could feasibly
be higher or lower than 10%, we investigated values of 20% and 5% as well, which are within
the range of detection for eQTL studies with hundreds of samples [51–55]. The default medi-
ated trait variance explained value of 1% for a single gene is likely high, given that a recent pub-
lication using GTEx data has estimated the proportion of heritability mediated by expression
across all genes to be around 11% (±2%) averaging over 42 traits, with the top mediated traits
having around 30% of heritability mediated by expression [1]. We therefore considered even
lower expression mediated heritability of the GWAS trait, h2med of 0.5% and 0.1%, as well as a
null simulation where gene expression did not mediate the downstream trait in any way (0%).
We note that the selection of simulated loci with two or more nearly-LD-independent eQTL
with index eSNP p-value < 0.001 may result in Winner’s Curse for low-powered studies,
where true values tend to be smaller than the estimated coefficients for the eSNPs passing a sig-
nificance threshold. Over-estimation of instrument effect sizes would then result in under-esti-
mation of the mediation effect. There was some over-estimation for the lowest gene
heritability (h2g = 0.05), but a balance of both under- and overestimation of effect sizes for h2g
of 0.1 or 0.2 (Fig D in S1 Text).
For the default values of 10% gene h2 and 1% h2med (simulation A), eCAVIAR-MRLocus
had the highest accuracy in terms of relative mean absolute error (RMAE), dividing the error
by the absolute value of the true slope, followed by MRLocus and PTWAS (Fig 2A). TWMR
and PTWAS demonstrated the most negative bias, calculated using the sample mean of the
estimator and the population-level α. The bias for TWMR, PTWAS, MRLocus, and eCA-
VIAR-MRLocus was -0.112, -0.079, -0.003, and -0.053, respectively. In addition, only eCA-
VIAR-MRLocus and MRLocus were able to achieve nominal coverage for 80% credible
Fig 2. Performance of methods on simulated eQTL and GWAS datasets. (A) Estimates of each method over true (simulated) gene-to-trait
values. The method denoted with “causal” indicates an inverse variance weighted slope estimation using the true causal SNPs but the estimated
coefficients and SEs (an oracle estimate), and “all” indicates an inverse variance weighted slope estimation using all SNPs. (B) Observed coverage
(abbreviated “cov.”) of 80% confidence or credible intervals from each method. If the interval contains the true effect size, it is colored black,
otherwise red.
https://doi.org/10.1371/journal.pgen.1009455.g002
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intervals over the true values, while other methods had lower observed coverage, having too
narrow confidence intervals (Fig 2B). We additionally tested two other methods, LDA-MR-Eg-
ger and PMR-Summary-Egger at the default twas_sim settings (Fig E in S1 Text). These addi-
tional two methods had higher error compared to other methods at the default twas_sim
settings (with LDA-MR-Egger having lower error of the two), and so we focused on the latter
three methods for further evaluation. Here, and in all simulation settings considered, the eval-
uated methods had higher RMAE of gene-to-trait slope compared to an oracle method that
uses only the true causal SNPs (which are generally not known) and their estimated coeffi-
cients (“causal”) in IVW regression with fixed effects [44].
In the evaluation of pairwise r2 across signal clusters, for loci with 4, 6, or 8 signal clusters,
increase in the r2 of adjacent signals was associated with an increase in the false positive rate
for MRLocus (Fig F in S1 Text). False positive rate was measured by the rate of 80% credible
intervals not covering the true value of α = 0, for 400 simulation iterations per combination of
simulation parameters. At r2 < 0.05, the average rate of intervals not covering 0 was approxi-
mately 20%, so MRLocus was then achieving the nominal level. We therefore recommend
trimming signal clusters to achieve r2 < 0.05 across pairs of clusters before running MRLocus
slope estimation, because allowing higher pairwise r2 across instruments could lead to loss of
nominal interval coverage. A convenience function in the MRLocus package, trimClusters,
can be used to prioritize signal clusters with higher strength of eQTL signal. Violin plots of the
pairwise r2 across clusters, for all instruments passed to MRLocus slope fitting is provided in
Fig G in S1 Text.
We modified simulation A in two ways, to assess how horizontal pleiotropy or higher sam-
ple size would worsen or improve estimation of partial mediation, respectively. The effect of
horizontal pleiotropy, i.e. signals associated separately with gene expression and trait, on esti-
mation of gene-to-trait mediation was assessed by adding non-expression associated GWAS
signals to a loci exhibiting partial mediation. An example region plot for one of the HP simula-
tion iterations is provided in Fig H in S1 Text. TWMR, PTWAS, MRLocus, and eCA-
VIAR-MRLocus had higher error and lower interval coverage for the horizontal pleiotropy
simulation compared to their performance in simulation A, as expected (Fig I in S1 Text, with
additional methods provided in Fig J in S1 Text). MRLocus and eCAVIAR-MRLocus had
nearly the same RMAE, which was the lowest among the methods tested. LDA-MR-Egger was
less affected by inclusion of trait-only signals, although still having higher error than all other
methods except for PMR-Summary-Egger. MRLocus and eCAVIAR-MRLocus obtained close
to 80% coverage (86% and 76%, respectively) despite the addition of coincident trait-only
GWAS signals. Finally, for the same default h2g and h2med settings as simulation A, we
increased the sample size to NeQTL = 1,000 to see how higher power in detection of instru-
ments may translate to better estimation of mediation. In this higher power setting, all meth-
ods had lower error in estimating the gene-to-trait effect (Fig K in S1 Text). Here, MRLocus
had the lowest RMAE, slightly below that of eCAVIAR-MRLocus, and both obtained nominal
interval coverage. PTWAS had improved confidence interval coverage (from 28% to 50%)
while other methods had similar coverage as with NeQTL = 500.
For simulations using other parameter settings of gene expression heritability h2g and
expression mediated trait heritability h2med, MRLocus had the second lowest RMAE in 6 of
the remaining 8 non-null simulation settings with non-default values of h2g and h2med (Figs
L-S in S1 Text). In simulation G, with 10% h2g and 0.1% h2med, PTWAS had lower RMAE
than MRLocus, and in simulation H, with 20% h2g and 0.1% h2med, eCAVIAR-MRLocus had
lower RMAE than MRLocus and PTWAS. Overall, considering the non-null simulations per-
formed, MRLocus or eCAVIAR-MRLocus had the lowest RMAE in estimating the gene-to-
trait effect compared to other methods for 10 out of 11 of the settings (Fig 2, and Figs I, K-P,
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R-S in S1 Text). When expression heritability and mediated heritability were moderate to high
(h2g� 10%, h2med� 0.5%), these two methods would come close to the RMAE of the oracle
estimate ("causal").
In terms of credible or confidence interval coverage, MRLocus and eCAVIAR-MRLocus
always had better or equal coverage of the true values compared to all other methods within
the non-null simulation settings, though it did not always reach the nominal level (Figs T-AA
in S1 Text). When expression heritability was low (h2g = 5%), or the mediated trait heritability
low (h2med = 0.1%) MRLocus and eCAVIAR-MRLocus had coverage roughly in the range
50–70%; exceptions to this trend were that MRLocus achieved >80% coverage for simulation
F, and both methods had>80% coverage for simulation H. MRLocus always had higher cover-
age than eCAVIAR-MRLocus when they differed by more than 5%. PTWAS tended to have
higher coverage than TWMR, but they each had a maximal coverage of 39% and 26%, respec-
tively; TWMR and PTWAS had the best coverage on the h2g = 20%, h2med = 0.1% simulation.
The oracle method tended to have narrow confidence intervals, and MRLocus had higher cov-
erage than the oracle method for all simulations. The maximal coverage of the oracle was simu-
lation F with 40%. We believe the lower-than-nominal coverage seen here for the oracle
method is likely from insufficient propagation of error during slope estimation. As the twas_-
sim framework does not include heterogeneity of effects from different signal clusters, an addi-
tional simulation was performed to assess MRLocus’s estimation of the dispersion of effects
around the gene-to-trait fitted line (Fig AB in S1 Text). Here, MRLocus was accurate both in
estimation of the dispersion and quantification of uncertainty (attaining nominal credible
interval coverage), with higher accuracy and smaller intervals as the number of nearly-LD-
independent clusters increased, as expected.
In the 3 null simulation settings with h2g of 5%, 10%, 20% but no mediated heritability, and
trait-only GWAS signals, MRLocus always had the highest interval coverage of the true slope
value of 0 (average of 79%, close to the nominal 80%), followed by eCAVIAR-MRLocus (aver-
age of 63%) (Fig AC in S1 Text). Here, TWMR had average coverage of 35% and PTWAS had
average coverage of 38%. The oracle method with the true eQTL SNPs had average coverage of
14%. The oracle method again had too narrow intervals as in the non-null simulations.
TWMR and PTWAS had lower mean absolute error (MAE) for estimating α = 0 than MRLo-
cus and eCAVIAR-MRLocus, which was expected due to the bias toward 0 seen in the non-
null simulations.
We performed sensitivity analysis for the two thresholds involved in the formation of signal
clusters: the eQTL p-value used with PLINK clump (default of p-value < 0.001), and the PIP
threshold for inclusion of a signal cluster to PTWAS causal effect estimation (default of
PIP > 0.5). While p-value < 0.001 corresponds to an F-statistic > ~10.8, use of stronger crite-
ria for the eQTL instruments (p< 0.0001, F-statistic > 15.1) did not result in higher accuracy
or better interval coverage for MRLocus in simulation A or with higher NeQTL = 1,000 (Fig AD
in S1 Text). However, in both simulation settings, accuracy and coverage were improved
slightly for TWMR using the stricter p-value for clumping. Running PTWAS with PIP thresh-
old lowered from the default value of 0.5 to 0.1 did not improve accuracy or interval coverage
in these simulation settings.
We assessed whether MRLocus colocalization step or eCAVIAR was more accurate at iden-
tifying the causal eSNP in non-null and null simulations. eCAVIAR outperformed MRLocus
on the non-null simulations in its ability to detect the true causal SNP, for all 11 non-null sim-
ulations (Fig AE in S1 Text). We note that eCAVIAR does not provide posterior estimates of
eQTL and GWAS effect sizes, the originally designed input to the MRLocus slope fitting step.
When providing eCAVIAR-chosen SNPs and the original estimated coefficients from eQTL
and GWAS, we find that eCAVIAR-MRLocus is more accurate for only 2 out of 11 non-null
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simulations (simulation A and H). Furthermore, MRLocus generally had higher coverage of
the gene-to-trait effect compared to eCAVIAR-MRLocus in the more difficult simulation set-
tings (simulations C, F, and I, while eCAVIAR-MRLocus had higher coverage for simulation
G). For the null simulations, in which eQTL eSNPs and GWAS trait-associated SNPs are dis-
tinct and expression does not mediate trait variance, MRLocus colocalization was always more
accurate at identifying the true causal eSNP, and the MRLocus-chosen eSNPs were better for
providing intervals that cover the true gene-to-trait effect (α = 0).
Insufficient confidence or credible interval coverage could result from estimator bias, and
TWMR and PTWAS exhibited downward bias in the simulations. We further examined if cal-
culating and removing the estimator bias (using the true, population-level slope α) improved
interval coverage for TWMR, PTWAS, MRLocus and eCAVIAR-MRLocus, for the simula-
tions with h2g of 10% (simulation A, D, and G). In some cases, bias removal helped substan-
tially, for example TWMR’s coverage rising from 14% to 67% in simulation A and from 8% to
59% in simulation D, or PTWAS’s coverage rising from 35% to 76% in simulation G (Fig AF
in S1 Text). Still, even with this "oracle" bias removal, TWMR and PTWAS still had cases of
insufficient coverage, for example PTWAS with 32% coverage in simulation D, and TWMR
with 44% coverage in simulation G. This indicated that the insufficient coverage observed for
these methods was not only due to bias, but also from too small standard errors on the causal
effect estimate.
We assessed method timing across the 80 main (A) and high NeQTL simulations. MRLocus
was approximately 17 times slower than TWMR and 32 times slower than PTWAS, with a
mean running time per locus of 75 seconds compared to 4.3 seconds for TWMR and 2.3 sec-
onds for PTWAS (Fig AG in S1 Text). The additional elapsed time is because MRLocus
involves a colocalization step with model fitting per signal cluster using MCMC. MRLocus
colocalization step was provided with four cores for running four MCMC chains, while other
methods and MRLocus slope fitting used a single core. Performing colocalization with eCA-
VIAR reduced the running time by about two-thirds for eCAVIAR-MRLocus compared to
MRLocus (3.4 seconds for eCAVIAR colocalization and 22 seconds for MRLocus slope fitting,
so in total 6 times slower than TWMR and 11 times slower than PTWAS). One reason why
MRLocus colocalization is slower than eCAVIAR is that MRLocus’s model for colocalization
adapts its priors for eQTL and GWAS effect sizes to the data in each signal cluster in terms of
the scale and sparsity of causal variants. Runtime for PLINK clumping and DAP were not
included in the times presented above.
Real data analysis
We compared TWMR, PTWAS, MRLocus, and eCAVIAR-MRLocus using eQTL and GWAS
summary statistics for five gene-trait pairs in which there is strong evidence that the gene
mediates the trait, and the direction of the effect has also been reported, such that we could
compare our estimates against the literature. For one gene-trait pair (LIPC and HDL), we
examined the effect in liver, the tissue reported in literature as the relevant gene expression
context, as well as using eQTL in blood, where the expression association signal may or may
not provide strong evidence of mediation of the GWAS trait. LocusZoom-style plots [56,57]
for the eQTL and GWAS tracks are provided in Figs AH-AL in S1 Text. Additionally, the LD
patterns for all trimmed signal clusters are provided in Figs AM-AR in S1 Text.
On the six eQTL-GWAS dataset pairs, all four methods had consistent sign of the mediating
effect (Fig 3). MRLocus and eCAVIAR-MRLocus generally had larger credible intervals com-
pared to confidence intervals from the other two methods, as was seen in the simulation data-
sets where MRLocus and eCAVIAR-MRLocus had improved coverage of the true effect size.
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In all cases except LIPC in blood, the sign of the mediating effect was in concordance with lit-
erature: higher SORT1 (liver) expression decreasing LDL levels [19,58,59], higher MRAS
(artery) being hazardous for CAD [60–62], higher PHACTR1 (artery) being protective for
CAD [63,64], higher CETP (liver) decreasing HDL levels [65], and higher LIPC (liver) decreas-
ing HDL levels [66]. For LIPC assayed in blood, TWMR and PTWAS have positive effect sizes
with narrow confidence intervals (opposite of the mediating effect for LIPC in liver), while
MRLocus and eCAVIAR-MRLocus have large credible intervals, reflecting the conflicting evi-
dence across blood eQTL signal clusters (Figs AS and AT in S1 Text). We note that MRLocus
also has large credible intervals for LIPC in liver, due to a limited number of nearly-LD-inde-
pendent signal clusters (n = 3) and posterior GWAS effect sizes close to 0 for two signal clus-
ters (Fig AS in S1 Text). For CETP (liver) paired with HDL, PTWAS did not have any DAP
signal clusters with sufficient PIP (threshold of 0.5) to estimate an effect, so the threshold was
lowered to 0.1, which produced an estimate close to 0, while MRLocus and eCAVIAR-MRLo-
cus likewise displayed high uncertainty of mediation given the limited number of signal clus-
ters (n = 2 for both, Figs AS and AT in S1 Text).
MRLocus had the strongest evidence for mediation with SORT1 (liver) and its effect on LDL,
with LocusZoom-style plot of the region in Fig 4A and MRLocus gene-to-trait estimate plot in
Fig 4B. The number of signal clusters used for MRLocus for SORT1 (liver), MRAS (artery),
PHACTR1 (artery), CETP (liver), LIPC (liver), and LIPC (blood) were: {6, 9, 5, 2, 3, 31}, and for
eCAVIAR-MRLocus were: {5, 5, 6, 2, 3, 28}. The number of nearly-LD-independent signal clus-
ters for blood eQTL for LIPC (n = 31 and 28 for MRLocus and eCAVIAR-MRLocus, respec-
tively) is likely an overestimate of the number of true causal SNPs at this locus, and new
methods for clumping or summary-based conditional analysis large-sample-size meta-analysis
eQTL studies may refine these signals. MRLocus and eCAVIAR-MRLocus also had strong evi-
dence for mediation with PHACTR1 (artery) and its effect on CAD. Two loci where MRLocus
and eCAVIAR-MRLocus have slightly differing results were MRAS (artery) on CAD and LIPC
(liver) on HDL, where MRLocus-selected instruments tended to have more scatter (Fig AS in
S1 Text), and thus more uncertainty reflected in the credible interval of the gene-to-trait effect.
Estimates of heterogeneity and dispersion for PTWAS and MRLocus are shown in Table 1.
PTWAS indicates heterogeneity of instruments using an I2 statistic that ranges from 0 to 1
Fig 3. Estimated gene-to-trait effects for TWMR, PTWAS, and MRLocus on five eQTL and GWAS datasets for
strong candidate genes for mediation of the GWAS trait and one auxiliary tissue example (LIPC in blood). 80%
confidence or credible intervals are shown (MRLocus provides quantile-based credible intervals). The artery eQTL
were estimated from inverse normal transformed expression data from GTEx, transformed z-scores for eQTLGen,
while the liver meta-analysis eQTL were estimated from log2 expression data, thus the estimated slopes represent
changes in SD of artery or blood gene expression on log odds for CAD risk and on SDs of lipid levels, and doubling of
liver gene expression on SDs of lipid levels.
https://doi.org/10.1371/journal.pgen.1009455.g003
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(low to high heterogeneity). MRLocus estimates the dispersion of instruments around the fit-
ted line on the scale of the mediation effect; the estimate can be compared across loci by calcu-
lating the mean mediated effect: (estimate α) x (mean of estimated coefficients for βj
A).
Visually, the mean mediated effect is the y-axis value from the fitted slope in Fig 4B corre-
sponding to the middle values of estimated eQTL coefficients. The ratio of the estimate of dis-
persion σ over the absolute value of mean mediated effect indicates relatively how much the
effects from nearly-LD-independent signal clusters vary around the conditional mean. The
lowest I2 for PTWAS was for MRAS and LIPC (liver), which each had an estimate of 0 for
Table 1. I2 statistic for PTWAS and dispersion estimate σ from MRLocus for eQTL-GWAS pairs.
Gene (tissue)—trait PTWAS I2 MRLocus σ Mean mediated σ / |MM|
SORT1 (liver)—LDL 0.85 1.47 -0.062 0.17
MRAS (art.)—CAD 0.00 0.16 0.014 0.91
PHACTR1 (art.)—CAD 0.76 0.12 -0.044 0.71
CETP (liver)—HDL 0.92 0.17 -0.12 1.43
LIPC (liver)—HDL 0.00 0.14 -0.028 1.30
LIPC (blood)—HDL 0.29 0.12 0.0051 7.16
Additional columns provide the mean mediated effect for MRLocus, and the ratio of the dispersion to the absolute value of the mean mediated effect.
https://doi.org/10.1371/journal.pgen.1009455.t001
Fig 4. Colocalization and MRLocus estimation for SORT1. (A) Colocalized signals in the SORT1 region. From top panel to bottom, gene model (NCBI
Refseq), eQTL for SORT1 in liver (N = 588) (Strunz et al., 2018) and LDL association within UKBB (N = 343,621). Dashed line indicates a significance
threshold at p = 0.001 or p = 5x10-8 for eQTL and GWAS respectively. Colored labels indicate eSNPs used for slope fitting with both methods,
eCAVIAR-MRLocus, or MRLocus. (B) MRLocus plot of the gene-to-trait effect for SORT1 expression in liver on LDL levels. The signal clusters all provide
consistent evidence for a gene-to-trait effect of -0.042, meaning that doubling of gene expression level in liver should reduce LDL by 4.2% of its population
standard deviation. An 80% credible interval for the slope is indicated by dashed blue lines around the solid blue slope, while a range of heterogeneity of allelic
effects is indicated by the light blue band.
https://doi.org/10.1371/journal.pgen.1009455.g004
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heterogeneity. The lowest dispersion relative to the mean mediated effect for MRLocus was for
SORT1, followed by PHACTR1 and MRAS.
On the six gene-tissue-trait combinations, eCAVIAR colocalization took an average of 6
seconds per locus, MRLocus slope fitting following eCAVIAR took an average of 18 seconds
per locus, and MRLocus (both steps) took an average of ~4 minutes per locus, using 4 cores
for MRLocus colocalization step.
Discussion
Here, we introduce MRLocus, a two-step Bayesian statistical procedure for estimation of gene-
to-trait effects from eQTL and GWAS summary statistics. We find that MRLocus tends to
have high accuracy in estimating the gene-to-trait effect across a variety of simulation settings,
often higher than existing methods, and always had better credible interval coverage of true
values, whether in partial mediation or null simulations. On real data analyses, MRLocus and
eCAVIAR-MRLocus (using eCAVIAR for colocalization followed by MRLocus slope fitting)
had consistent sign of estimates and comparable effect size compared to TWMR and PTWAS,
but larger credible intervals compared to the other methods’ confidence intervals. While the
effect sizes of alleles detected by GWAS on downstream traits examined here may be moder-
ate, MRLocus’s estimation of the causal effect from perturbation of gene expression can be
helpful in assessing the impact of therapeutic effects modulating expression on downstream
traits [67]. For various systems, different downstream trait effect sizes qualify as practically
meaningful increases or decreases, and MRLocus provides a framework for assessing what
level of gene expression perturbation may be needed to obtain such changes in a downstream
trait.
MRLocus was used to estimate the gene-to-trait effect following colocalization with MRLo-
cus’s own Bayesian model of eQTL and GWAS coefficients per signal cluster, and alternatively
using the existing eCAVIAR method. Both approaches were found to perform well in simula-
tions, and better than other methods in terms of accuracy and interval coverage of the true
slope. Use of eCAVIAR sped up the pipeline substantially (by at least an order of magnitude
after accounting for use of multiple cores), as colocalization in MRLocus is the slowest step.
eCAVIAR was better on average at identifying the true causal eSNP for non-null simulations,
although MRLocus was better at identifying true causal eSNP in the null simulations. In simu-
lation settings when expression heritability was high (h2g> 5%), passing original estimated
coefficients for eCAVIAR-identified SNPs to slope fitting performed just as well as passing
MRLocus’s posterior estimates for MRLocus-identified SNPs. However, when expression heri-
tability was lower (h2g = 5%), MRLocus had a more substantial gain in accuracy in estimating
the gene-to-trait effect over eCAVIAR-MRLocus. This advantage may be due to the shrinkage
of the eQTL/GWAS effect sizes that occurs in the MRLocus colocalization step (eCAVIAR
does not provide posterior estimates of effect size). Also, in the h2g = 5% simulations, eCA-
VIAR-MRLocus had moderate coverage of the true effect (48–58%), while MRLocus had
closer to nominal coverage (68–87%). In the real data loci, the two alternatives for colocaliza-
tion input to MRLocus slope fitting had similar output, except for the case of MRAS (artery)
and LIPC (liver) where MRLocus had a larger interval, intersecting with 0. Overall, we recom-
mend MRLocus over eCAVIAR-MRLocus for general purpose estimation of gene-to-trait
effects, but both are provided as options in the MRLocus software guide.
While the mediator evaluated by MRLocus in this work was gene expression effects via
eQTL, the methods are generic, and protein abundance effects via pQTL could be used instead
of eQTL. Two-sample MR linking pQTL and GWAS has already uncovered 30 metabolite fea-
tures with evidence of causal effects on at least one disease [68], and a recent pQTL study of
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hepatic proteins reported a median of 4.5 local pQTL variants per protein [69], suggesting that
there are loci with sufficient number of nearly-LD-independent clusters for MR analysis. Addi-
tionally, large scale pQTL studies of similar sample size to eQTLGen (>30,000 individuals)
have uncovered secondary pQTL signals upon conditional analysis for hundreds of loci [70].
Alternatively, pQTL could be used in place of the downstream GWAS trait in order to study
mediation from gene expression to protein abundance [71], as previous work has found pQTL
effect size to be positively correlated with eQTL effect size for variants ascertained through
eQTL in human [72,73], and that colocalized eQTL and pQTL signal leads to higher observed
RNA-protein correlations in mice [74].
Given MRLocus’s improved performance with respect to interval coverage in the simula-
tion, we feel that accurate estimation of uncertainty is an advantage to MRLocus, and the focus
in developing a new method was on specificity for prioritization of gene targets for functional
follow-up experiments. Additionally, the MRLocus model is extensible. The slope-fitting
model could easily be generalized to use an alternative monotonic function, as long as there
are sufficient nearly-LD-independent signal clusters to support fitting. On the other hand,
MRLocus’s slower speed means it is likely not the best choice for a global scan of the transcrip-
tome for mediating genes, while the other methods examined and discussed here have been
successfully used to scan across all genes and across multiple tissues. Furthermore, MRLocus is
designed for investigating loci with strong causal gene candidates, whereas other methods that
estimate gene-to-trait effects for many genes in a locus simultaneously may have less biased
estimation of the effect, when a strong gene candidate is not present. Future work on the
MRLocus model may involve estimation of the mediating effect of candidate causal genes in
the context of other relevant genes in a pathway and a polygenic background [75].
There are a number of important limitations of the current study. First, the 1000 Genome
Project phase 3 (1KG EUR) was used for LD calculations and clumping on the real data loci,
although this reference panel is now a small sample size compared to other available resources
such as gnomAD, TOPMed, and UK Biobank [76–78]. In addition, new tools such as TopLD
(http://topld.genetics.unc.edu/topld/) allow for easy access to LD based on TOPMed whole
genome sequencing data. MRLocus and other methods for estimating mediation effects would
benefit from these larger reference panels for LD calculations. Another important limitation is
that, as eQTL study sample sizes increase, the threshold of eQTL p-value < 0.001 for clumping
and inclusion of eQTL instruments may prove to be too lenient, as could be seen in the large
number of nearly-LD-independent loci with small eQTL effect size for LIPC in blood from
eQTLGen (Figs AS and AT in S1 Text). More sophisticated statistical methods for performing
conditional analyses from summary statistics would benefit downstream analyses such as
MRLocus that make use of nearly-LD-independent signal clusters, and stricter instrument
inclusion criteria may be needed for large studies and meta-analyses with ancestry heterogene-
ity across studies.
We note that our method focuses on common variation (MAF> 0.01), and that we collapse
highly correlated SNPs to a single representative SNP during the pre-processing, such that we
cannot determine if the final selected SNP is the true "causal" SNP. Future development of
MRLocus could involve upstream use of methods defining credible sets [79–84] or modeling
based on a posterior inclusion probability as in LLARRMA or DAP [33,85]. Therefore, the cur-
rent implementation of MRLocus can perform fine-mapping to the level of a highly correlated
set of SNPs, which may be sufficient for identifying one or more regulatory elements (RE) to
prioritize for functional follow-up experiments. The current implementation of MRLocus
assumes that the mediation slope passes through the origin, and therefore that eQTL signal
clusters do not affect the downstream trait through genes other than the eGene. Estimation
was nevertheless shown to be robust when loci harbored large trait-only association signals.
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Further iterations of MRLocus could relax this assumption through the addition of an inter-
cept term accounting for invalid instruments as in MR-Egger [86,87]. Complementary infor-
mation linking RE to genes, e.g. as measured by Hi-C, was not examined here, but have been
proven successful elsewhere (HUGIN [88], H-MAGMA [89]), and we envision that prioritiza-
tion of signal clusters in MRLocus that are supported by Hi-C would increase its power to
detect causal genes.
As part of the MR analysis, MRLocus provides an estimate of the dispersion of effects
around the estimated slope from nearly-LD-independent signal clusters, analogous to
PTWAS’ use of the I2 statistic for effect size heterogeneity. The combined information from
PTWAS and MRLocus regarding both uncertainty in estimation of the gene-to-trait slope, and
estimated dispersion or heterogeneity of effects is critical when modeling context-specific (e.g.
relevant tissue, cell type, or developmental stage) gene expression as a mediator for down-
stream traits. Different combinations of eQTL and GWAS SE (primarily influenced by sample
size), extent of heterogeneity of effects, and the number of nearly-LD-independent signal clus-
ters within a locus all may give rise to the same gene-to-trait effect and SE, but disentangling
these sources of variance is important for experimental planning. For example, consider exper-
imental follow-up for endophenotype downstream traits that could be feasibly measured in
vitro. An investigator could choose between modulating gene expression directly or modulat-
ing the activity of an RE harboring candidate causal SNPs. A nonzero gene-to-trait effect with
narrow credible interval estimated by MRLocus (as in Figs 1A and 4B) would suggest that
modulating the gene directly or via the activity of an RE should affect the downstream trait,
and the predicted effect could be assessed experimentally. However, high dispersion around
the gene-to-trait slope (as in Fig 1B) suggests that perturbation of an RE implicated by candi-
date causal SNPs may induce an effect on the trait that is far from the effect size indicated by
the fitted line, such that modulation of the gene directly may prove more successful. MRLocus
provides a band around the predominant gene-to-trait slope, such that functional experiments
per RE can therefore be prioritized. In all, here we demonstrate the MRLocus method and soft-
ware utilizing summary statistics from eQTL and GWAS to identify genes mediating traits
that can be prioritized for experimental follow-up.
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